Contact
Please use this form to send email to PR contact of this press release:
Innate Pharma acquires anti-C5aR, a first-in-class clinical-stage antibody, from Novo Nordisk A/S
TO:
Please use this form to send email to PR contact of this press release:
Innate Pharma acquires anti-C5aR, a first-in-class clinical-stage antibody, from Novo Nordisk A/S
TO: